Immune checkpoint blockade in renal cell carcinoma [electronic resource] / David McDermott.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Immunotherapy of cancer: ; Henry Stewart talksBiomedical & life sciences collection. Kidney in health and disease: Publisher: London : Henry Stewart Talks, 2016Description: 1 online resource (1 streaming video file (58 min.) : color, sound)Subject(s): Antineoplastic agents | Cancer -- Immunological aspects | Immunotherapy | Kidneys -- Cancer -- Chemotherapy | Kidneys -- Cancer -- Immunological aspects | Renal cell carcinoma | Antibodies, Monoclonal -- therapeutic use | Antineoplastic Agents -- therapeutic use | Carcinoma, Renal Cell -- drug therapy | Carcinoma, Renal Cell -- immunology | Cell Cycle Checkpoints | Clinical Trials as Topic | Combined Modality Therapy | CTLA-4 Antigen -- immunology | Immunotherapy -- methods | Kidney Neoplasms -- drug therapy | Kidney Neoplasms -- immunology | Patient Selection | Programmed Cell Death 1 Receptor -- antagonists & inhibitors | T-Lymphocytes -- immunologyOnline resources: Click here to access online | Series (Immunotherapy of cancer) | Series (Kidney in health and disease) Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Recent data that has led to the approval of PD-1 blockade in RCC -- Approaches to patient selection -- Novel combination therapies that are entering pivotal trials.
Access restricted to subscribers.
Mode of access: World Wide Web.